These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 9245614)
1. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Bartz SR; Vodicka MA Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614 [TBL] [Abstract][Full Text] [Related]
2. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Haglund K; Forman J; Kräusslich HG; Rose JK Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333 [TBL] [Abstract][Full Text] [Related]
3. Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus. Ohishi M; Shioda T; Sakuragi J Virology; 2007 May; 362(1):131-8. PubMed ID: 17258261 [TBL] [Abstract][Full Text] [Related]
4. Kinetic analyses of stability of simple and complex retroviral vectors. Higashikawa F; Chang L Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826 [TBL] [Abstract][Full Text] [Related]
5. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications. Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519 [TBL] [Abstract][Full Text] [Related]
6. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein. Kameyama Y; Kawabe Y; Ito A; Kamihira M J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189 [TBL] [Abstract][Full Text] [Related]
8. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Reiser J Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Kuate S; Stahl-Hennig C; Stoiber H; Nchinda G; Floto A; Franz M; Sauermann U; Bredl S; Deml L; Ignatius R; Norley S; Racz P; Tenner-Racz K; Steinman RM; Wagner R; Uberla K Virology; 2006 Jul; 351(1):133-44. PubMed ID: 16616946 [TBL] [Abstract][Full Text] [Related]
10. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Desmaris N; Bosch A; Salaün C; Petit C; Prévost MC; Tordo N; Perrin P; Schwartz O; de Rocquigny H; Heard JM Mol Ther; 2001 Aug; 4(2):149-56. PubMed ID: 11482987 [TBL] [Abstract][Full Text] [Related]
11. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. Akkina RK; Walton RM; Chen ML; Li QX; Planelles V; Chen IS J Virol; 1996 Apr; 70(4):2581-5. PubMed ID: 8642689 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells. Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590 [TBL] [Abstract][Full Text] [Related]
13. Optimized large-scale production of high titer lentivirus vector pseudotypes. Sena-Esteves M; Tebbets JC; Steffens S; Crombleholme T; Flake AW J Virol Methods; 2004 Dec; 122(2):131-9. PubMed ID: 15542136 [TBL] [Abstract][Full Text] [Related]
14. Gene transfer in human skin with different pseudotyped HIV-based vectors. Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532 [TBL] [Abstract][Full Text] [Related]
15. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095 [TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor-alpha stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner. Kfutwah AK; Mary JY; Nicola MA; Blaise-Boisseau S; Barré-Sinoussi F; Ayouba A; Menu E Retrovirology; 2006 Jun; 3():36. PubMed ID: 16796744 [TBL] [Abstract][Full Text] [Related]
17. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192 [TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions. Kahl CA; Pollok K; Haneline LS; Cornetta K Mol Ther; 2005 Mar; 11(3):470-82. PubMed ID: 15727944 [TBL] [Abstract][Full Text] [Related]
19. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Arai T; Takada M; Ui M; Iba H Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362 [TBL] [Abstract][Full Text] [Related]
20. [High efficiency gene transfer into breast cancer cells by pseudotyped retroviral vector]. Tang LL; Yu H Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):48-50. PubMed ID: 12536615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]